In a continuing drive to close the health gap between African Americans and the majority population, pharmaceutical and biotechnology companies are developing nearly 700 new medicines for disease that disproportionately afflict African Americans or diseases that are among the top 10 causes of death among African Americans, according to a new report.

Report: 2007: Medicines in Development for Major Diseases Affecting African Americans (PDF)

Informe: 2007: Medicamentos en Desarrollode para las Enfermedades Principales que Afectan a los Afroamericanos (PDF)

Press Release: New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline

Backgrounder: Selected Medicines in Development for Major Diseases Affecting African Americans